Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of PERP mRNA | increases expression | 16788091
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of PERP mRNA | affects expression | 18648102
|
C015001 |
arsenite |
arsenite results in decreased expression of PERP mRNA | decreases expression | 18929588
|
C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in decreased expression of PERP mRNA] | affects reaction|decreases expression | 18929588
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of PERP mRNA | increases expression | 20064835
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of PERP mRNA | increases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of PERP mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PERP mRNA] | decreases reaction|increases expression | 17854601
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of PERP mRNA | increases expression | 16243910
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PERP mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PERP mRNA | increases expression | 17557909
|
D015073 |
2-Acetylaminofluorene |
TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of PERP mRNA] | affects expression|affects reaction | 17317680
|
C482205 |
nutlin 3 |
nutlin 3 results in increased expression of PERP mRNA | increases expression | 16949053
|
C041786 |
palm oil |
palm oil results in increased expression of PERP mRNA | increases expression | 18042831
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PERP mRNA | increases expression | 18301758
|
C059514 |
resveratrol |
resveratrol results in increased expression of PERP mRNA | increases expression | 15767336
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PERP mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PERP mRNA | increases expression | 17035482 18796159
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PERP mRNA | increases expression | 18796159
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 14514962 11752688 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.04 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.90 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.17 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.14 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.14 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.14 | 14692618 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
21.36 | 10737359 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
21.36 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
21.36 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
21.36 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
resveratrol |
21.36 | 15688382 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
6.11 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.78 | 17620307 19052882 19061943 18056438 17162532 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.78 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.78 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.61 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.58 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
10.15 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.15 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.47 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.47 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.30 | 17967414 16873680 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.12 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.95 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.95 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.80 | 14601052 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.37 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.86 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.98 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.98 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.98 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.98 | 11325840 18628466 18382427 16096432 15634643 16264153 16935488 15994142 17983394 15692762 17426702 15993339 16595493 18695136 18234424 16826403 16115903 15136595 17369602 16322301 15668708 15939500 15567936 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.98 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.98 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.91 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
8.99 | 3084413 10737359 3581430 6705139 17761372 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.99 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
8.99 | 20101231 18393292 19383236 16935385 16830150 18210153 20007298 19539802 20432363 17761372 18056438 17978847 18665156 18506893 18788625 16328049 16681979 16288022 19822196 3084413 16807293 19208518 16779866 10672840 17055752 19052882 19919837 20524982 18978308 11831363 10737359 19171122 19418558 17428255 20512989 20727157 18494052 19701751 18971187 20214788 19519916 20935162 3581430 16569478 19335982 17138121 19394651 20514400 20084675 16502159 16878318 17173139 16698587 18691550 16540662 17162532 21159647 18785209 19107877 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.99 | 18059187 16023760 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
8.99 | 19321006 16227395 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.67 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.63 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.63 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.69 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.69 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.69 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.56 | 17924179 16731534 17928571 18627295 17329180 17519947 16455267 16651473 16242529 17131338 15792986 17382496 16612575 17974986 15811867 16364871 16952015 16269455 16278810 16109756 17007740 15505089 17351982 15476868 17308081 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.96 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.51 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.81 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.81 | 17174075 7505956 2727394 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.49 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.49 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.61 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.61 | 16919318 17110522 17681005 17333356 16105132 11677210 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.61 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 16354765 12621046 15340226 15668235 8697196 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.20 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
4.07 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
4.07 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.74 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.74 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.78 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.87 | 12868966 11906362 11298694 2524372 8970840 8156756 18759878 14531868 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.45 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.55 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.81 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.26 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
4.01 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
9.11 | 8291058 6482804 18289764 9022650 18692083 9328219 9653073 1440618 16192314 6679447 18648102 11289319 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.11 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
9.11 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.11 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.24 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.24 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.49 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.75 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
11.75 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.75 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.34 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.34 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.48 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.25 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.92 | 17923197 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.21 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.40 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.40 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
25.28 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
25.28 | 18296743 19004024 19551842 17967931 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
25.28 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
25.28 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
25.28 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.12 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.67 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
15.28 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
15.28 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.28 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.38 | 17150277 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.10 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.56 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.54 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.54 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.52 | 18674790 17875725 12587719 18006777 16330681 16244372 16144979 16495754 16879835 14766674 16707910 16244371 17888722 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.16 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.16 | 20558911 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
5.41 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
9.59 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
9.59 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.58 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.50 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.50 | 15340226 12621046 16120746 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.26 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.45 | 15147373 18501091 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 18606429 8697196 16959395 15340226 16354765 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
9.40 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
9.40 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.23 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
9.49 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.49 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.01 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.92 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.35 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.88 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.72 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.52 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.52 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
12.20 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
12.20 | 18785209 |
MESH:D007249 |
Inflammation |
|
resveratrol |
12.20 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
12.20 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.64 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.36 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.36 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.12 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.08 | 15369732 15699352 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.21 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.01 | 6582329 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.25 | 16085563 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.61 | 16087638 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
11.27 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
11.27 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
11.27 | 20032147 18407596 18522880 18665156 19638242 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.23 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.47 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.47 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.47 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.11 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
18.26 | 18001218 10737359 16273603 11376686 14678523 10672840 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
18.26 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.26 | 21278145 19255062 19294768 19996281 19638242 21047994 12112319 16942905 9163691 21167192 20137499 21071580 19690152 19642983 19254457 20405173 12771043 19073162 19426721 18978307 19499222 10737359 20452335 19551842 15175105 20118626 18644402 19850985 19256749 2422723 20101389 19427195 19812893 15885732 18648771 19833225 18754104 20583210 18977376 20501860 19090486 20434301 2862719 20492335 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
18.26 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
18.26 | 19812893 19073162 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
18.26 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
19.03 | 6150874 1399818 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
19.03 | 598648 1399818 3712494 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
19.03 | 19009564 18079962 16267830 18164116 18308698 18544905 19126423 18253720 17174075 18775883 2563599 16842330 18093689 18282651 17854601 19539802 19004024 21159647 9362446 19519916 17942915 3124819 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
19.03 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.03 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
8.65 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
8.65 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.65 | 18569708 20869020 18816296 20064080 6695378 18520028 20135361 17053015 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.65 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.65 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.65 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.50 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.36 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.03 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
9.03 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.64 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.33 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.43 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.43 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.62 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.62 | 17992120 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.08 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.43 | 17112576 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.55 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.23 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.87 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.50 | 16267019 16490592 17935668 17049120 17164350 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.95 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.58 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.63 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.63 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.63 | 17188708 17125593 16456233 16317513 17015251 16525036 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.16 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.16 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.99 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.84 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.63 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.63 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.63 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.90 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.90 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.07 | 8985016 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.49 | 15738583 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.84 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.05 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.28 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.95 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.29 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.68 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.68 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.46 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.21 | 20387270 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.47 | 16723640 19632207 17217161 21332399 18457598 20518802 11836018 18674790 20132043 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.47 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.47 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.12 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.31 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.16 | 15930896 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.44 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.75 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.55 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.57 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.25 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.25 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.60 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.87 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.87 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.62 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.62 | 15749863 16729912 16888761 15897917 18437689 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.62 | 17636462 16731767 17675339 15767336 17804756 17718901 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.39 | 16919318 15861022 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.29 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.68 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.65 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.65 | 17520802 17058453 15827377 16317513 16314181 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.41 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.04 | 15675481 17203757 17710206 15625365 18313854 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.31 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.87 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.78 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.78 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.78 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.78 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.64 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.04 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.34 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.34 | 18456281 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.53 | 16321402 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.68 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.20 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.24 | 1399818 6582329 3712494 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
12.24 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
12.24 | 16010429 17909728 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.26 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
12.14 | 15289314 15867355 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.14 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
12.14 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
12.14 | 17653716 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.15 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.72 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.72 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.59 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
10.58 | 17638931 17334414 17678736 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
10.58 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.79 | 16723640 |